Page 1 of Clinical Trials for Peritoneal Neoplasms, 632 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
Quality of Life Questionnaire for Pediatric Patients Undergoing Peritoneal Perfusion
Last Updated: January 9, 2012
Condition(s): Peritoneal Neoplasms
2
Completed
Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer
Last Updated: March 29, 2012
Condition(s): Peritoneal Neoplasms; Retroperitoneal Neoplasms; Gastrointestinal Neoplasms; Adenocarcinoma; Neuroblastoma; Ovarian Neoplasms; Sarcoma; Adrenocortical Carcinoma; Wilms Tumor; Rhabdomyosarcoma; Desmoplastic Small Round Cell Tumor
3
Completed
Phase II Study in Patients With Epidermal Growth Factor Receptor (EGFR) + Advanced Stage Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Last Updated: April 7, 2010
Condition(s): Ovarian Cancer; Peritoneal Neoplasms; Fallopian Tube Neoplasms
4
Completed
Vandetanib to Treat Women With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Last Updated: May 17, 2011
Condition(s): Ovarian Neoplasms; Fallopian Tube Neoplasms; Peritoneal Neoplasms
5
Completed
EPO906 Therapy in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer
Last Updated: April 13, 2012
Condition(s): Ovarian Neoplasms; Peritoneal Neoplasms; Fallopian Tube Neoplasms
6
Completed
Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer
Last Updated: May 2, 2012
Condition(s): Ovarian Cancer; Fallopian Tube Cancer; Peritoneal Neoplasms
7
Recruiting
Pharmacokinetic, Safety and Efficacy Study of Nanoparticle Paclitaxel in Patients With Peritoneal Cancers
Last Updated: April 6, 2012
Condition(s): Peritoneal Neoplasms
8
Active, not recruiting
Topotecan and Gefitinib (Iressa) for Ovarian, Peritoneal, or Fallopian Tube Cancer
Last Updated: October 18, 2011
Condition(s): Ovarian Cancer; Peritoneal Neoplasms; Fallopian Tube Cancer
9
Active, not recruiting
Correlation of the Chemoresponse Assay With PFS in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer
Last Updated: January 9, 2012
Condition(s): Ovarian Cancer; Fallopian Tube Cancer; Peritoneal Neoplasms
10
Completed
A Study of Carboplatin and DOXIL Plus Bevacizumab in Patients With Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers
Last Updated: July 7, 2011
Condition(s): Ovarian Neoplasms; Fallopian Tube Neoplasms; Peritoneal Neoplasms
11
Terminated
A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer
Last Updated: March 9, 2012
Condition(s): Ovarian Cancer; Peritoneal Neoplasms
12
Completed
Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 To Treat Small-Volume Ovarian, Peritoneal, Fallopian Tube Cancer
Last Updated: November 6, 2006
Condition(s): Ovarian Neoplasms; Peritoneal Neoplasms; Fallopian Tube Neoplasms
13
Completed
Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinoma
Last Updated: November 3, 2010
Condition(s): Ovarian Carcinoma; Peritoneal Neoplasms
14
Completed
OVCA-NAC-P2: Study of Chemotherapy Followed by Cytoreductive Surgery for Ovarian, Tubal and Peritoneal Cancers: JCOG0206
Last Updated: February 29, 2008
Condition(s): Ovarian Neoplasms; Fallopian Tube Neoplasms; Peritoneal Neoplasms
15
Completed
Testing Drug Sensitivity of Ovarian, Fallopian and Primary Peritoneal Adenocarcinomas
Last Updated: March 23, 2011
Condition(s): Adenocarcinoma; Ovarian Neoplasms; Fallopian Tube Neoplasms; Peritoneal Neoplasms
16
Terminated
ABI-007 With Carboplatin as First-Line Therapy in Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Carcinoma
Last Updated: April 6, 2012
Condition(s): Fallopian Tube Neoplasms; Peritoneal Neoplasms; Ovarian Neoplasms
17
Completed
Use of ACA 125 in Patients With Ovarian Cancer: Safety and Immune Response
Last Updated: September 29, 2006
Condition(s): Ovarian Cancer; Fallopian Tube Neoplasms; Peritoneal Neoplasms
18
Completed
A Randomized Trial for Patients With Platinum Resistant Ovarian, Fallopian or Primary Peritoneal Cancer.
Last Updated: January 24, 2007
Condition(s): Genital Neoplasms, Female; Fallopian Tube Neoplasms; Ovarian Neoplasms; Pelvic Neoplasms; Peritoneal Neoplasms
19
Completed
Phase I Study of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Escalating Dose I.P. Platinum for Gastrointestinal Peritoneal Carcinomatosis
Last Updated: March 3, 2008
Condition(s): Peritoneal Neoplasms; Stomach Neoplasms
20
Completed
OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer
Last Updated: February 23, 2012
Condition(s): Fallopian Tube Cancer; Peritoneal Neoplasms; Ovarian Cancer

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Peritoneal+Neoplasms

Page 1 of Clinical Trials for Peritoneal Neoplasms, 632 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About